Patient Tolerability Study of GSK163090

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to determine the safety and tolerability of a new drug, GSK163090, which is being developed for the treatment of depression and anxiety disorders.
Epistemonikos ID: e96d3cf0811ac757c270850a42009bba97f6289f
First added on: May 04, 2024